Search Results - "Toschi, Alexandria"
-
1
Androgen receptor (AR) amplification in patients with metastatic castration-resistant prostate cancer (mCRPC) refractory to therapy with abiraterone acetate or enzalutamide: Preliminary results from the SU2C/PCF/AACR West Coast Prostate Cancer Dream Team (WCDT)
Published in Journal of clinical oncology (20-05-2014)“…Abstract only…”
Get full text
Journal Article -
2
Identifying enzalutamide resistance mechanisms in men with castration-resistant prostate cancer
Published in Journal of clinical oncology (20-05-2014)“…Abstract only…”
Get full text
Journal Article -
3
Androgen receptor (AR) amplification in patients (pts) with metastatic castration resistant prostate cancer (mCRPC) resistant to abiraterone (Abi) and enzalutamide (Enz): Preliminary results from the SU2C/PCF/AACR West Coast Prostate Cancer Dream Team (WCDT)
Published in Journal of clinical oncology (20-05-2015)“…Abstract only…”
Get full text
Journal Article -
4
Molecular profiling of metastatic castration-resistant prostate cancer (mCRPC): Preliminary results from the SU2C/PCF/AACR West Coast Prostate Cancer Dream Team (WCDT)
Published in Journal of clinical oncology (20-05-2014)“…Abstract only…”
Get full text
Journal Article -
5
Pathway-based signature analysis of RNA-seq data to reveal new targetable avenues for metastatic castration-resistant prostate cancer (mCRPC) patients (pts): Preliminary results from the SU2C/PCF/AACR West Coast Prostate Cancer Dream Team (WCDT)
Published in Journal of clinical oncology (20-05-2014)“…Abstract only…”
Get full text
Journal Article